Navigation Links
Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show
Date:5/21/2013

TEANECK, N.J., May 21, 2013 /PRNewswire-iReach/ -- The 2013 Pharma ChemOutsourcing Show slated for Sept 17-19 in NJ has attracted the greatest number of "Emerging" small molecule biotech company chemists ever, reports its President, Mark Alexay .  "No one saw this coming", commented Alexay.  "But suddenly everyone plans to attend this year.  The show's still 4 months away and we may end up attracting hundreds of different companies.  This is a big surprise and great news for attendees". Thecurrent list of 80 attending pharmaceutical, emerging, virtual, and other small molecule biotech companies is at http://chemoutsourcing.com/popup.php

Alexay elaborated, "The Emerging companies need timely information about how to get their molecules scaled up quickly and properly.  They also need to meet their suppliers in one place.  This is why they attend.  It's makes efficient use of their time without trips to Europe or Asia."    

"They have also remarked that it's helpful to benchmark best practices and meet their peers from other small molecule biotech companies.  There's no other show in the world that brings together so many chemists from "Emerging" and "Virtual" companies.  If small and lean is the new pharmaceutical industry drug development model then the show is well-positioned to serve it."

Pharma ChemOutsourcing is now in its 7th year and takes place every September at the Jersey Shore.  The show annually attracts 700-800 Pharmaceutical company chemists and suppliers of chemical services to the industry. The show emphasizes Outsourcing of Discovery and Medicinal Chemistry, Process Research, and  Chemical Development of Intermediates, API's, and Commercial Manufacturing.

"The goal from the outset was for the show to develop into an annual pharma chemist "cult classic" and it's taken the better part of a decade for that to happen",  Alexay continued.  "We're finally seeing the fruition of this vision.  People have made it clear that it serves a vital purpose for the industry by and makes good use of the scarcest resource of all – their time." 

The other major 2013 development announcement is that ChemOutsourcing has integrated the conference panel sessions into the exhibit halls.  As Alexay commented "In 2013 buyers and sellers will be integrated all day in a single area, the exhibit halls, where they will have ample opportunity to interact.  This completely changes the feel of the show".   

"In years past because attendees and exhibitors were segregated for large portions of the day it was awkward to meet new people and buyers were reluctant to enter the halls. Now the spontaneity and easy intimacy has been restored because everyone will be together without forced contact".  The current 2013 Exhibitor List may be found at http://chemoutsourcing.com/sponsors.php

Media Contact:

mark alexay, apaporis, llc, 201-452-4023, malexay@chemoutsourcing.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Apaporis, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer
2. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company launch educational campaign about emerging science in type 2 diabetes
3. NextDocs Launches QuickStart for Emerging Growth Companies
4. Treatment Adherence Emerging as Critical Theme in Improving Quality and Cost of US Healthcare
5. For Treatment of Extensive-Disease Small-Cell Lung Cancer (ED-SCLC), No Emerging Therapy is Likely to Replace Etoposide/Carboplatin as the Standard of Care Before 2022
6. Details of New Synthetic Vaccine for Emerging H7N9 Threat Revealed at BIO International Convention in Chicago, April 22-25
7. GlaxoSmithKline and A*STARs Institute of Chemical Engineering and Sciences to Develop new Medicines for Emerging Markets
8. For the Treatment of Lupus, the Emerging Therapies Epratuzumab and Lupuzor Have the Potential to Offer Improvements Over IV Belimumab in Reducing Disease Activity
9. Emerging Precision Medicine Powerhouse Changes Name to Increase Visibility and Overall Awesomeness
10. Emerging Data From Upsher-Smiths CNS Portfolio Highlighted At 2013 American Academy Of Neurology Meeting
11. Innophos CFO To Present At 2013 Sidoti Emerging Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... 26, 2016 Story Highlights: ... models within the health care industry is causing providers ... , Deloitte offers a suite of solutions for ... impacting efficient cost optimization: labor resource analysis, revenue cycle ... facilitate better outcomes and better economics ...
(Date:6/24/2016)... N.J. , June 24, 2016  Collagen ... the design, development and manufacturing of collagen and ... regeneration announced today that Bill Messer ... and Marketing to further leverage the growing portfolio ... medical devices. Bill joins the Collagen ...
(Date:6/24/2016)... June 24, 2016   Bay Area Lyme ... Dean Center for Tick Borne Illness , ... Rehabilitation, MIT Hacking Medicine, University of California, Berkeley, ... announced the five finalists of Lyme Innovation ... More than 100 scientists, clinicians, researchers, entrepreneurs, and ...
Breaking Medicine Technology:
(Date:6/26/2016)... Cary, North Carolina (PRWEB) , ... June 26, 2016 , ... ... the release of a new product that was developed to enhance the health of ... harvested for centuries. , The two main herbs in the PawPaws Cat Kidney ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
Breaking Medicine News(10 mins):